Unlock stock picks and a broker-level newsfeed that powers Wall Street.

3 Penny Stocks With Market Caps Up To $300M

In This Article:

As the U.S. stock market faces turbulence with recent declines driven by tariff concerns and recession fears, investors are looking for opportunities beyond the major indices. Penny stocks, though often seen as remnants of past market trends, remain relevant due to their potential for growth and value in smaller or newer companies. In this article, we explore three penny stocks that stand out for their financial resilience and potential to offer long-term success amid current market challenges.

Top 10 Penny Stocks In The United States

Name

Share Price

Market Cap

Financial Health Rating

Safe Bulkers (NYSE:SB)

$3.67

$400.14M

★★★★☆☆

BAB (OTCPK:BABB)

$0.81695

$5.74M

★★★★★★

Sensus Healthcare (NasdaqCM:SRTS)

$4.35

$75.88M

★★★★★★

QuantaSing Group (NasdaqGM:QSG)

$3.08

$126.25M

★★★★★★

PHX Minerals (NYSE:PHX)

$3.65

$137.93M

★★★★★☆

Golden Growers Cooperative (OTCPK:GGRO.U)

$4.50

$67.38M

★★★★★★

Imperial Petroleum (NasdaqCM:IMPP)

$2.32

$72.49M

★★★★★★

Tuya (NYSE:TUYA)

$3.79

$2.4B

★★★★★★

CBAK Energy Technology (NasdaqCM:CBAT)

$0.8712

$80.45M

★★★★★☆

TETRA Technologies (NYSE:TTI)

$3.28

$439.55M

★★★★☆☆

Click here to see the full list of 766 stocks from our US Penny Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

QuantaSing Group

Simply Wall St Financial Health Rating: ★★★★★★

Overview: QuantaSing Group Limited offers online learning services in the People’s Republic of China and has a market cap of approximately $126.25 million.

Operations: The company's revenue is derived entirely from its operations in the People’s Republic of China, amounting to CN¥3.74 billion.

Market Cap: $126.25M

QuantaSing Group, with a market cap of US$126.25 million, operates in the online learning sector in China. Despite its classification as a penny stock, it has demonstrated significant earnings growth of 839.8% over the past year and maintains an outstanding return on equity of 66.3%. The company is debt-free and has short-term assets exceeding both short- and long-term liabilities, indicating solid financial health. However, earnings are forecast to decline by an average of 25.6% annually over the next three years, raising concerns about future profitability despite current high-quality earnings performance. Recent board changes include the appointment of Mr. Shunyan Zhu as an independent director, bringing notable experience from Alibaba Health Information Technology Ltd., potentially strengthening governance amidst these challenges.